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Abstract
Machine learning techniques have recently received considerable attention, especially when
used for the construction of prediction models from data. Despite their potential advantages
over standard statistical methods, like their ability to model non-linear relationships and
construct symbolic and interpretable models, their applications to survival analysis are at
best rare, primarily because of the difficulty to appropriately handle censored data. In this
paper we propose a schema that enables the use of classification methods — including
machine learning classifiers — for survival analysis. To appropriately consider the follow-up
time and censoring, we propose a technique that, for the patients for which the event did not
occur and have short follow-up times, estimates their probability of event and assigns them
a distribution of outcome accordingly. Since most machine learning techniques do not deal
with outcome distributions, the schema is implemented using weighted examples. To show
the utility of the proposed technique, we investigate a particular problem of building
prognostic models for prostate cancer recurrence, where the sole prediction of the probability
of event (and not its probability dependency on time) is of interest. A case study on
preoperative and postoperative prostate cancer recurrence prediction shows that by incorpo-
rating this weighting technique the machine learning tools stand beside modern statistical
methods and may, by inducing symbolic recurrence models, provide further insight to
relationships within the modeled data. © 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Among prognostic modeling techniques that induce models from medical data,
the survival analysis methods are specific both in terms of modeling and the type
of data required. The survival data normally include the censor variable, which
indicates whether some outcome under observation (like death or recurrence of a
disease) has occurred within some patient-specific follow-up time. The modeling
technique must then consider that for some patients the follow-up may end before
the event occurs. In other words, it must take into account that for patients for
whom the event has not occurred during the follow-up period, the event may
eventually occur.
Typically, given the patient’s data, survival models attempt to determine the
probability of the event to occur within a specific time. Frequently, however, there
are cases in survival analysis where the prediction of whether the event will
eventually occur or not is of primary importance. For example, for the urologist
deciding whether to operate on patients with clinically localized prostate cancer,
the probability of cancer recurrence is a very important decision factor. In such
cases, the survival analysis requires purely classification models that classify either
to the occurrence or to the non-occurrence of event and optionally model the
outcome probabilities, and appropriately consider the censoring.
Recently, the machine learning community has developed various tools that
have been successfully used in the construction of classification models, including
medical prognostic models [15,18]. In this paper, we propose a framework which
allows us to use machine learning techniques to construct classification models
from survival data. To properly address censoring in the training data, patients for
whom the event did not occur and have short follow-up time require special
treatment. Note that for them the final outcome is not known with certainty.
Trivial solutions to this problem by their removal from the data set or considering
them as examples where the event will not occur would bias the modeling [22,12]
and should thus be avoided. To properly treat such cases, we propose a technique
that assigns a distribution of outcomes instead of a single outcome. The distribu-
tion is assessed through the outcome probability estimate based on the Kaplan–
Meier method. Since most machine learning techniques do not deal with outcome
distributions, the schema is implemented using weighted examples. Although devel-
oped independently, the proposed technique is similar to the one used by Ripley
and Ripley [22]. The main difference, however, is that they use data weighting only
when testing the models, whereas for their construction different approaches are
used.
The benefits of the proposed framework stem from the potential advantages of
machine learning methods. Symbolic induction techniques can help us to under-
stand underlying relationships in the prostate cancer data. Some machine learning
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techniques can discover and use non-linearities and variable interactions [12], thus
overcoming the limitations of linear statistical predictors.
We investigate the applicability of the proposed framework to the problem of
modeling prostate cancer survival data and use two different machine learning
methods. While any machine learning method that induces models from weighted
examples may be used, a naive Bayes classifier and induction of decision trees were
selected for our study because of their simplicity, acceptance and generally good
performance. The two were compared to the Cox proportional hazards model [6],
which is a standard statistical survival analysis technique for prediction based on
multiple variables.
We use two separate datasets to construct the prostate cancer survival models.
The preoperative data set includes data on tests that were administered prior to the
prostatectomy (prostate removal), while postoperative dataset also includes data
from several routinely performed pathologic tests. Preoperative data are generally
fully known at least 2 weeks prior to the operation, while postoperative data
generally are complete approximately a month following the operation. Clinically,
both prediction models would be very useful. A model based on preoperative data
could be used for patient decision making as to whether the ability of prostatec-
tomy is worth the potential treatment complications (impotence and incontinence).
If the predicted probability of recurrence were high, patients might choose one of
several other treatments which did not have the adverse effects of such an
aggressive therapy. Postoperatively, a prediction model is also useful, but for
different purposes. If recurrence could be predicted postoperatively, prior to actual
recurrence, a second therapy (after the prostatectomy) could be administered
quickly, when it is potentially the most effective. Thus, preoperative and postoper-
ative prediction models are both very useful but for different purposes: deciding
whether to undergo prostatectomy at all, and then whether to add additional
treatment.
In Section 2 we begin by describing two prostate cancer datasets used in our
experimental evaluation. The proposed treatment of censored data that uses
outcome distributions (data weighting) is described in Section 3, together with a
description of machine learning techniques, experimental design and statistics that
were used to compare the performance of resulting models. Section 4 presents the
experimental results and discusses the differences and advantages of selected
prediction methods. An overview of related work is given in Section 5. Section 6
summarizes the results and concludes the paper.
2. Patient data
Two prostate cancer datasets were used in this study. They both include patients
that were treated with radical prostatectomy, and were followed-up to observe the
recurrence of the cancer. While the first dataset includes only preoperative data, the
second dataset additionally incorporates data gathered postoperatively. The task in
both cases was to construct a model that would, given the corresponding patient’s
data, predict the probability of recurrence.
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2.1. Preoperati6e data
The preoperative dataset consists of records from all 1055 patients admitted to
The Methodist Hospital (Houston, TX) with the intent to operate on their clinically
localized prostate cancer between June 1983 and December 1996. Excluded from
analysis were 55 men initially treated with radiation, and one treated with cryother-
apy. Sixteen men whose disease status (free of disease versus cancer recurrence) was
unknown were also excluded. The mean age was 63 years and 85% of the patients
were Caucasian.
Four routinely performed clinical tests were selected as predictors of recurrence
(Table 1). Treatment failure was defined as either clinical evidence of cancer
recurrence or an abnormal postoperative PSA (0.4 ng:ml and rising) on at least one
additional evaluation. Patients who were treated with hormonal therapy (N8) or
radiotherapy (N25) after surgery but before documented recurrence were treated
as failures at the time of second therapy. Patients who had their operation aborted
due to positive lymph nodes (N24) were considered immediate treatment failures.
To accommodate for some of the modeling methods used (S-Plus implementation
of Cox’s proportional hazards model), we additionally excluded 16 men having
either primary or secondary or both Gleason grades unknown. For the naive Bayes
classifier, the PSA level was discretized using five intervals by computing the
quintals from the training data.
The resulting dataset thus included 967 patients, of which 189 (19.5%) recurred,
and of those that did not recur 68 had follow-up time of equal or longer than 7
years (7.0%) and 710 (73.4%) shorter than 7 years. For the last group, the mean
follow-up time was 37.5 months.
2.2. Postoperati6e data
All 1055 patients mentioned above, plus those additionally treated with radical
prostatectomy at the same hospital from December 1996 to June 1997 were
Table 1
Variable names and descriptive statistics for preoperative dataa
Variable Abbreviation Values and distributions
gg1 1 (14), 2 (260), 3 (594), 4 (95), 5 (4)Primary
Gleason
grade
gg2Secondary 1 (12), 2 (164), 3 (543), 4 (237), 5 (11)
Gleason
grade
Clinical stage Stage T1ab (82), T1c (145), T2a (264), T2b (239), T2c (180), T3a (57)
Continuous, min0.1, mean9.9, max100.0Preoperative PrePSA
PSA (ng:l)
a The numbers of corresponding patients are given in brackets.
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Table 2
Variable names and descriptive statistics for postoperative data
AbbreviationVariable Values and distributions
3 (2), 4 (5), 5 (106), 6 (350), 7 (454), 8 (61), 9 (14), 10 (4)GleasonGleason sum
PCI None (184), invading capsule (396), focal (152), established (264)Prostatic
capsular
invasion
Surgical margins SurgMarg Negative (853), positive (143)
No (862), yes (134)SemVesInvSeminal vesicle
invasion
Lymph nodes LNodes Negative (925), positive (71)
Continuous, min0.1, mean10.4, max100.0PrePSAPreoperative
PSA (ng:l)
candidates for the postoperative dataset. Excluded were patients with positive
lymph nodes and aborted operations (for a detailed description see Ref. [14]). The
final postoperative dataset includes 996 patients. In addition to pretreatment
prostate specific antigen level, five routinely performed pathologic tests were
included as variables: Gleason sum in the surgical specimen, prostatic capsular
invasion, surgical margin status, seminal vesicle invasion and lymph node status
(Table 2). The dataset includes 189 (19.0%) patients that recurred. Of those that did
not recur, 107 (10.7%) have follow-up time longer or equal to 7 years and 700
(70.3%) have follow-up time of less than 7 years.
3. Methods
The naive Bayes classifier and the induction of decision tree machine learning
methods were used and evaluated. Their performance was compared to a Cox
proportional hazards model on the basis of the classification accuracy, specificity
and sensitivity, correlation of predicted probability and probability estimated by the
Kaplan–Meier method, and concordance index (area under receiver operating
characteristic curve). We first explain how we treat censored data, then briefly
introduce the machine learning techniques, and finally describe the statistics used
for comparison.
3.1. Handling censored data
The particular characteristic of survival data is that for some patients the
follow-up is too short to determine a definite outcome. For example, it is assumed
that if the prostate cancer patient who has undergone radical prostatectomy
remains disease free for at least 7 years [12], the cancer has been successfully cured.
However, if a non-recurrent patient has been followed up for less than 7 years, the
outcome is not certain.
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The above reasoning provides motivation to split the prostate cancer survival
data into three groups: the first consists of patients that recurred (the outcome is
known), the second of patients that did not recur and were followed for more than
7 years after the operation (for these non-recurrence is assumed), and the third of
non-recurring patients with follow-up of less than 7 years. For the last group, we
assess the probability of each outcome using the Kaplan–Meier method [16]. In
essence, for prostate cancer the Kaplan–Meier method estimates the probability of
non-recurrence at a particular follow-up time. Fig. 1 gives the Kaplan–Meier
survival curve for the preoperative dataset used in this study. It illustrates the
overall proportion of patients who remain free from recurrence over time. Time
begins with surgery, so the horizontal axis is months following surgery. As time
increases, a smaller proportion of patients are left without recurrence. The Kaplan–
Meier survival curve for the postoperative dataset is similar to the one shown for
preoperative data.
Using Kaplan–Meier estimates from all groups of patients, we compute the
probability Prf of recurrence-free outcome for each of the patients from the third
group. Given the patient’s follow-up time Tf, this probability is equal to:




The patient’s probability of recurrence is then Pr1Prf. The outcome for this
patient is, therefore, a distribution (Prf, Pr). Since most of the machine learning
tools do not include mechanisms to handle distributions as class values, instead of
a single data record for each patient from the third group, two copies of the
patient’s data are created, one labeled with an outcome ‘not-recurred’ and weighted
with weight Prf, and the other with an outcome ‘recurred’ and weighted with weight
Pr.
Fig. 1. Plot of the Kaplan–Meier survival probability estimates for the preoperative dataset.
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3.2. Modeling techniques
Induction of decision trees and naı¨ve Bayes machine learning method were used
to construct prognostic models from data. They were compared to Cox’s propor-
tional hazards model, which is a standard statistical technique for modelling
censored data.
3.2.1. Decision tree induction
Our own implementation of the ID3 recursive partitioning algorithm [21] was
used. The basic idea of ID3 is to divide the patients into ever smaller groups until
creating the groups with all or a majority of patients corresponding to the same
class (recurrent, non-recurrent). The division criterion is a function computed from
predictor variables. The decision tree induction algorithm included pre- and post-
pruning. In pre-pruning, the recursive partitioning is stopped if it would build
leaves consisting of less than 20 data records. We observed in cross-validation
experiments that when this limit was lowered, the performance degraded signifi-
cantly. For post-prunning, a minimal-error pruning algorithm [20] using the
m-probability estimate [5] with m2.0 was used.
3.2.2. Nai6e Bayes classifier
Assuming independence of attributes, the probability that a patient described







where P(R) is the apriori probability of recurrence and P(R 6i) is the conditional
probability of recurrence if the ith predictor variable has the value 6i ; both are
estimated from the training set of patients. Note that this formula can be derived
from the more common form P(R V)P(R):P(V)i P(6i R) by reusing the Bayes
rule P(6iR)P(R 6i)P(6i):P(R). The probability for non-recurrence is computed in
the same way and the resulting probabilities must be normalized to sum to 1.
3.2.3. Cox’s proportional hazards model
Cox’s proportional hazards model [6] as implemented in the S-PLUS software
(PC Version 4.5; Redmond, WA) was used. Using the Cox’s model for prediction,
the probability was estimated for the patients to recur within 7 years after the
operation.
Decision trees and naive Bayes classifiers are constructed from weighted data (see
Section 3.1). The treatment of the weighted examples is fairly straightforward. Both
algorithms need to estimate conditional and unconditional probabilities of classes.
Instead of the usual formula which divides the number of examples of class C with
the number of all considered examples (P(C) (cexamples of C):(cexamples)),
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3.3. Experimental design and e6aluation statistics
To evaluate the proposed weighting schema and the modeling methods, a
standard technique of stratified 10-fold cross-validation was used [19]. This divides
the patient data set into ten sets of approximately equal size and equal distribution
of recurrent and non-recurrent patients. In each experiment a single set is used for
testing the model that has been developed from the remaining nine sets. The
evaluation statistics for each method is then assessed as an average of ten
experiments. The same training and test data sets were used for all modeling
methods. The weights for the non-recurring patients with short follow-ups were
estimated by building the Kaplan–Meier survival curve from the patients in the
training sets only, and then used to weight the patients in the corresponding test sets.
To assess the performance of the model on the test datasets, the following statistics
were derived:
— Classification accuracy, which is expressed in percent of patients in the test set
that were classified correctly. A recurrence probability of higher than 0.5 was
considered as a prediction for a patient to recur.
— Sensiti6ity expressed as the probability of correctly predicting recurrence.
— Specificity expressed as the probability of correctly predicting non-recurrence.
Correlation of the predicted probability with recurrence-free probabilities esti-
mated from Kaplan–Meier survival curves as described in the previous section.
— Concordance index, which is a measure developed by Harrell et al. [10] and is
interpreted as the probability that, given two randomly drawn patients where the
patient with the shorter follow-up has recurred, the patient who recurs first has
a higher predicted probability of recurrence. Notice that this is equivalent to the
area under the receiver operating curve [9]. The concordance index is computed
from the test data set as a proportion of consistent patient pairs over the number
of usable patient pairs. A patient pair is usable if a patient with a shorter
follow-up time recurred. A pair is consistent, if the patient with a shorter
follow-up time is assigned a higher probability of recurrence.
Accuracy, sensitivity and specificity all use weights assigned to the test examples.
On the other hand, probability correlations and the concordance index do not need
information about weights.
4. Results and discussion
For preoperative data, Table 3 shows the results when applying different modeling
techniques. Overall, the naive Bayes and Cox proportional hazards model seem to
perform better than decision trees, although the differences are not significant.
The results for the concordance index are very similar to those reported in Kattan
et al. [13], although they have used a different validation technique (a repetitive
drawing of 70% cases for training while using the remaining 30% for testing). They
obtained 0.74 for the Cox’s proportional hazards model and 0.76 for
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Table 3
Results for preoperative data
ProbabilitySensitivityClassification SpecificityModeling Concordance
indexcorrelationaccuracytechnique
100.0 0.0068.1 0.50Default 0.0
70.8Naive Bayes 35.8 87.1 0.41 0.75
classifier
22.9Decision tree 90.368.8 0.37 0.72
induction
93.2 0.39 0.76Cox 19.569.7
ANN using null martingale residual as the outcome. In their later study [11], using
the Cox’s model only and bootstrapping for validation, they have obtained a
concordance index of 0.79.
Further differences among the performance of predictive methods when assessed
by 10-fold cross validation may be additionally analyzed by means of calibration
curves PKM(Pr) [24]. This is constructed as follows. Say that a patient with an
estimated probability of recurrence PKM by the Kaplan–Meier method is presented
to one of our prediction models, which predicts a recurrence probability of Pr. For
all non-recurrent patients with a follow-up time of more than 7 years PKM is
changed to 1.0 (see Section 3.1). For all patients, their corresponding points
PKM(Pr) are entered on the graph. Instead of these points, a smoothed curve which
best approximates the relationship between two probabilities is computed and
presented. Ideally, a calibration curve would be a 45° straight line PKMPr.
Fig. 2 shows calibration curves for the three modeling methods. The curves for
the naive Bayes classifier and Cox are rather similar, with a difference that the naive
Bayes classifier seems to become overconfident when predicting recurrence with a
probability close to 1. This may be the reason for the higher sensitivity of the naive
Bayes classifier. The plot for the decision trees is interesting since it is very close to
the ideal curve, but shows that decision trees predict probabilities only within a
certain range.
Fig. 2. Calibration curves for the preoperative data.
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A classification tree induced from the complete preoperative data set is given in
Fig. 3. The tree is relatively small and simple but in concordance with physiological
knowledge on this domain, and uses preoperative PSA followed by secondary
Gleason grade and clinical stage as the most predictive variables. Our previous
study [25] using a different weighting technique developed a decision tree with
secondary Gleason grade at its root. The differences between these trees may be
attributed to the high similarity in terms of informativity of the predictive variables.
Thus for this domain, a relatively small change in data (change in weights) may
result in different classification trees.
Next, a naive Bayes classifier was constructed from a complete preoperative data
set. To analyze it we here show a graphical device called a nomogram [17] that uses
the naive Bayes formula to compute recurrence probability. The nomogram (Fig. 4)
shows the impact of individual features on the probability of recurrence (lower
labels on feature lines) and non-recurrence (upper labels). The values to the right of
zero (bold vertical line) favor (non)recurrence and the values on the left speak
against it. For example, observe gg2 and non-recurrence on the nomogram for
preoperative data: values of 5 and 4 vote against, and values 3, 2 and 1 vote for
non-recurrence. The nomogram can be used to compute the probabilities of
outcomes. First, the impact factors for feature values must be summed for
recurrence and for non-recurrence. The sums are then converted into probability
estimates using the lookup graph below and, finally, normalized to sum to 1. For
example, a patient with preoperative data (gg13, gg23, PrePSA11, Stage
T2c) has the sum 0.050.10.050.050.05 against and 0.10.20.1
0.1 0.1 for recurrence. Approximation by the lookup table gives about 84% for
Fig. 3. Decision tree for preoperative prostrate cancer recurrence prediction. Leaf nodes give the
probability of recurrence and the number of patient records from which this probability was assessed.
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Fig. 4. Preoperative nomogram for predicting probability of recurrence and non-recurrence based on
probability estimates by the naive Bayes classifier.
non-recurrence and 18% for recurrence, which multiplied by (0.840.18)1, gives
the probabilities of 82% for and 18% against recurrence.
The nomogram also points out some specifics about the recurrence domain we
are modeling. It reveals that the two Gleason scores are very important factors for
the decision as their values are most dispersed through the score line that the
nomogram provides. It also shows that the other two factors used are informative
too, as their values are well dispersed as well. Note, though, that PSA was in our
study discretized and under a different discretization the results may not be the
same. The potential anomaly concerning the Stage attribute is evident. Namely, the
expected order of severity of stages would be T1ab, T1c, T2a, T2b, T2c, T3a, while
the nomogram suggests T1c, T1ab, T2b, T2a, T2c, T3a. This indicates that the data
may undersample this problem subspace, and further analysis (potentially using
additional data) is required to investigate the stage ordering.
For the experiments on postoperative data, the results are summarized in Table
4. As expected, these prognostic models perform, in general, better than with
preoperative data. This was expected, since, intuitively, the data gathered during or
after the invasive treatment should contain more predictive information than
preoperative non-invasive tests. Most importantly, classification accuracy and the
concordance index are improved. However, the sensitivity of all modeling tech-
B. Zupan et al. : Artificial Intelligence in Medicine 20 (2000) 59–7570
niques investigated is still low, most probably due to the dominance of non-recur-
rent patients in the data. Interestingly, a similar problem was observed by Ripley
and Ripley [22], who proposed to increase the cost of misclassifying recurrent
patients. Trivially, this can be done by setting the probability margin for recur-
rence from 0.5 to some lower value. For both datasets investigated, increasing
sensitivity may prove important when constructing prognostic models for clinical
use, but investigation of methods that would do so while maintaining other
properties of the models was beyond the scope of this paper.
Fig. 5 shows the postoperative calibration curves. Again, the curves are rather
similar, with the predictions of decision trees being limited to a narrower range
(specifically, very few patients are assigned probabilities of recurrence of higher
than 0.8). The naive Bayes classifier seems to overemphasize recurrence more than
Cox, hence higher sensitivity but lower specificity. Interestingly, although calibra-
tion curves would suggest larger differences between the two methods, Cox and
Bayes perform very similarly in respect to classification accuracy and the concor-
dance index. We should not forget, though, that calibration curves compare
predicted probabilities with those estimated from data, so they should only be
used for informative purposes and interpreted with caution.
Table 4
Results for postoperative data
ConcordanceModeling ProbabilityClassification SpecificitySensitivity
indexaccuracytechnique correlation
0.0Default 100.070.8 0.00 0.50
0.87Naive Bayes 78.4 26.5 89.1 0.62
classifier
0.84Decision tree 18.777.0 92.8 0.54
induction
94.2Cox 18.2 0.880.6479.0
Fig. 5. Calibration curves for the postoperative data.
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Fig. 6. Postoperative nomogram for predicting probability of recurrence and non-recurrence based on
probability estimates by the naive Bayes classifier.
The naive Bayes postoperative nomogram built from a complete postoperative
data set is presented in Fig. 6. It shows that while prostatic capsular invasion may
be the most predictive variable, others follow closely and for a good predictor all
predictive variables may need to be considered. Since decision trees take a minimal-
istic approach (the tree built from the whole dataset is rather small and does not
contain all predictive variables; see Fig. 7), this may be the reason for the slightly
poorer performance. The nomogram also shows that if any of the surgical margins,
seminal vesicle invasion or lymph nodes involvement are positive, this is strong
evidence for recurrence; if they are negative, they do not influence the result that
much.
Overall, for both prostate cancer recurrence domains, the collaborating domain
experts preferred nomograms over decision trees. The main reason was that the
nomograms considered all predictive variables, while when following different paths
in the decision trees only a selection of variables is used. Since all predictive
variables included in both studies were carefully selected and considered relevant,
the latter was viewed as a deficiency.
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5. Related work
While there exist various statistical techniques to model survival-type data (e.g.
Kaplan–Meier modeling and Cox’s regression [16]), machine learning techniques
that would appropriately consider censored data are rare. Most notable exceptions
come from the area of artificial neural networks, but even there the techniques vary
from ignoring censored patients to treating them properly through modeling the
hazard function. For instance, Snow et al. [23] developed a neural network to
predict recurrence after radical prostatectomy, but treated censored patients as
non-recurrent, thus disregarding follow-up time and potentially biasing the predic-
tions towards non-recurrence. A similar approach was used by Burke et al. [4],
where patients with short disease-free follow-up were excluded from the model.
Their approach would also bias the resulting model, this time towards predicting
higher probabilities for recurrence, since for the patients with short follow-up time
only those that recurred would be considered. To appropriately consider censoring,
Faraggi and Simon [8] used a similar schema as with Cox’s proportional hazards
model, but instead of using a log-linear relationship between the independent
variables and the underlying hazard function, they use an artificial neural network.
Biganzoli et al. [3] split follow-up time into non-overlapping intervals, used interval
information as an additional input to a neural network and used it to model the
probability of failure. A different approach is presented by Kattan et al. [13] that
also used a neural network, but instead they modeled the null martingale residual,
e.g. the difference between the observed and expected number of recurrences for the
given follow-up time. Their analysis shows that neural network may be superior
Fig. 7. Decision tree for postoperative prostrate cancer recurrence prediction. Leaf nodes give the
probability of recurrence and the number of patient records from which this probability was assessed.
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when compared to traditional statistical models, which seems to be attributed to
nonlinearities incorporated in the neural network model [12].
A comprehensive overview and classification of existing neural network-based
techniques for survival analysis is provided by Ripley and Ripley [22], while
D’Amico et al. [7] provide a list of artificial neural networks techniques that
specifically target the prostate cancer recurrence prediction.
Anand et al. [2] stress the need to develop the prognostic models that would,
instead of hazard or survival functions, explicitly provide a prognostic estimate for
an individual patient. They compare regression trees, k-nearest neighbors (k-NN)
and a regression variant of an artificial neural network to model the patient’s
survival time after being diagnosed with colorectal cancer. While they treat the
follow-up time for censored patient as the survival time, they propose and subse-
quently implement an extension of the k-NN method that appropriately treats
censoring both in the learning and the prediction phase [1].
Our aim to predict an overall probability of non-recurrence for an individual
patient is in line with the suggestion of Anand et al. [2] to construct prognostic
models with a directly useful prognostic estimate for a single patient. The idea of
weighting the patients is similar to the one proposed by Ripley and Ripley [22]. In
their experimental evaluation Ripley and Ripley used a heavy censored melanoma
dataset. To incorporate censored data in the test sets, they fitted Kaplan–Meier
survival curves and estimated their probabilities Ps of survival to the end of the
observed follow-up time. These patients then entered the test set with both possible
outcomes and probabilities Ps and 1Ps, respectively. This schema was only used
for testing, while for model induction either linear modeling or artificial neural nets
were used to learn proportional odds and hazards, or Weibull and log-logistic
survival. Interestingly, they have also used a neural network to directly predict the
outcome, but for this they omitted the censored patients in the learning set. The
work presented in this paper can thus be viewed as an extension to Ripley and
Ripley’s weighting schema from test to training dataset, thus enabling the use of
general type machine learning algorithms that handle weighed data and induce
classification models.
6. Conclusions
Deciding whether to operate on patients with clinically localized prostate cancer
frequently requires the urologist to classify patients into expected groups such as
‘remission’ or ‘recur’. In this paper we show that models for prostate cancer
recurrence that may potentially support the urologist’s decision making can be
induced from data using standard machine learning techniques, provided that
follow-up and censoring has been appropriately considered. For the latter, we
propose a weighting schema that allows us to include data records of non-recurrent
patients with short follow-up times in the dataset for modeling.
The main contribution of the work described should be viewed as an enabling
technology. Within our schema, any machine learning technique that induces
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classification models from weighted examples can be used for building prognostic
models from censored data. We exemplify this through two case studies of prostate
cancer recurrence and show that a very simple and basic machine learning tool, the
naive Bayes classifier, can stand beside a mature and often used statistical method
of Cox proportional hazards model which was crafted specifically for survival
analysis.
There are various other techniques for handling censored data that we mention
in the section on related work. In comparison with these techniques, the advantages
of the approach proposed in this paper are simplicity, straightforward integration
with standard machine learning techniques, and a comparable performance with the
well established statistical technique of Cox proportional hazards model.
The machine learning community has developed techniques that are more
elaborate than the two used in our study, and that may be better at discovering
nonlinearities and complex predictive variable combinations. With the recent
introduction of medical and laboratory information systems, we believe that as the
volume of clinical data grows both in the number of records and number of
variables stored, machine learning tools may become increasingly important in
mining censored data. In this respect, the schema proposed in this paper should
further be tested on bigger datasets, where variable selection, combination and
construction together with the interpretation of the resulting models may be crucial.
The authors strongly believe that, although tested only on prostate cancer
recurrence data, the proposed methods are applicable to general survival analysis
where the sole prediction of probability of event (and not its probability depen-
dency on time) is of interest. Furthermore, the proposed weighting technique may
be extended in a straightforward manner to predict the outcome at a given time
interval, thus making it applicable beyond the scope considered in this paper.
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